Early studies indicate that the compound – a dual activator of incretin and GIP receptors – may provide a considerable breakthrough in body reduction therapies. Unlike existing medications , this dual-action compound shows to influence food intake and energy utilization via multiple pathways . Despite further analysis is needed , current findi… Read More